Pharma could see a wave of M&A activity in 2024, says Jefferies' Michael Yee
Biotech boom ahead in 2024, top Jefferies analyst predicts on heels of Bristol Meyers-Karuna deal
Dyadic Presents at 2022 Jefferies Healthcare Conference
New cancer drug data announced: Here's what to know
Unveiling the 2024 Economic Landscape: Expert Predictions and Strategies
M&A: Moving On and Up | Milken Institute Global Conference 2024
JPモルガンのエルデエス氏、若手銀行員は1日12時間働く必要があると語る
BCNU Human Rights & Equity Conference - Keisha Jefferies
Warren Buffett: Private Equity Firms Are Typically Very Dishonest
We expect a rebound in dealmaking volume later this year: Jefferies Canada’s CEO Bruce Rothney
The question for Oracle is how much AI revenue will offset weakness, says Truist's Keith Lerner
Dow, S&P 500, Nasdaq waver as Wall Street braces for Election Day
These are the stocks to buy for the next 10 years
What Does An Equity Research Analyst ACTUALLY Do?
S&P 500 sets record, longest weekly win streak of 2024 as Netflix surges
Stock market today: Stocks sink as post-election rally fades, Fed spurs rate-cut rethink
Bloomberg Markets 10/10/2024
Artificial Intelligence and the Future of Healthcare and Biotech
Bloomberg Markets: The Close 09/25/2023
Investing: What sectors may have peaked, plus David Zervos the economy, labor market and more